$96 billion revenue masks operational limits at Nvidia
The numbers are, by any metric—and I mean this in the most literal sense—staggering.
By Nikhil Raghavan ·
revenue — Lorien Times
Lego’s success signals manufactured nostalgia, not economic health
The narrative coming out of Billund is one of triumph.
By Imani Sutton ·
Walmart masks deceleration despite $2.9 billion tariff refunds
The corporate class has perfected the art of the optimistic press release—a carefully curated narrative designed to convince investors that the headwinds they themselves created…
By Emilio Quesada ·
Anthropic hype: a repeat of the Nasdaq Composite collapse
The sheer scale of the numbers being thrown around regarding Anthropic is not an indicator of durable economic strength; it is a measure of collective delusion.
By Klaus Berger ·
CoreWeave’s $104 billion backlog demands energy from the global south
The numbers are staggering, almost mythological in their sheer scale. CoreWeave’s Q2 revenue hit $2.58 billion, more than doubling from last year and fueling a massive 13% jump on August 11th.
By Sophie Naimi ·
Trade Desk guidance fails to meet analyst consensus for Q3 revenue
The market, bless its frantic heart, has a habit of mistaking temporary stability for enduring strength. This week, we saw that pattern play out in the ad-tech sector with Trade Desk (TTD).
By Adele Rutherford ·
Nintendo's profit boom shows US tariffs destabilize global finance
The numbers coming out of Nintendo are not a story of market strength; they are a textbook case study in financial sleight-of-hand.
By Tom Beckwith ·
Sandisk's $14 billion buybacks fail to stop Wall Street hype
It is always a peculiar thing to watch money move in these rarefied air currents of tech valuation.
By Caroline Ashford ·
Eli Lilly’s Mounjaro revenue is just modern-day oil money extraction
The quarterly earnings report is supposed to tell us about market health; instead, it’s another flashing neon sign of where America's care infrastructure has failed—and who gets rich from it.
By Josie Calloway ·
Lilly's $87 billion growth exceeds the scope of Congress or FDA
Eli Lilly’s Q2 2026 report isn't just a good quarter; it’s an inflection point that demands more than celebratory headlines.
By Nikhil Raghavan ·
Disney tops earnings estimates as parks and streaming offer a boost
The headlines are all about beats and boosts—Disney posted a substantial beat on earnings for its fiscal third quarter.
By Aoife Gallagher ·
McDonald's sales growth slows as budget-conscious consumers remain under stress
The numbers they feed us are always designed to look like a straight line going up, even when the car is actually coasting downhill.
By Imani Sutton ·
McDonald's is about to report earnings. Here's what to expect
The quarterly earnings call, for all its fanfare and ticker tape theatrics, is nothing more than an accounting exercise—a momentary snapshot designed to reassure investors while…
By Adele Rutherford ·
Tim Cook signed off on his final Apple earnings call with a warning about a ‘hundred year flood’ in memory chip pricing
I spent my morning reading the market comment in the Times of India, and I confess, I felt a familiar knot tighten in my stomach.
By Ruth Behrens ·
Apple posts record June quarter as iPhone sales surge; Cook weighs in on AI, China
The numbers coming out of Cupertino this week are staggering—and they demand to be viewed through a critical lens.
By Josie Calloway ·
Why Amazon (AMZN) Stock Is Jumping 10% Despite a Massive AI Capex Hike
When I read the reports detailing Amazon’s latest financial performance, one is struck by the sheer scale of it all. $220 billion.
By Caroline Ashford ·